vs
Axsome Therapeutics, Inc.（AXSM）与FIRSTSUN CAPITAL BANCORP（FSUN）财务数据对比。点击上方公司名可切换其他公司
Axsome Therapeutics, Inc.的季度营收约是FIRSTSUN CAPITAL BANCORP的1.7倍（$191.2M vs $110.0M），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（48.1% vs 6.9%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
FirstSun Capital Bancorp是一家总部位于美国的金融控股公司，提供商业及个人贷款、存款产品、财富管理、财资解决方案等全面的银行金融服务，主要面向美国区域市场的个人消费者、中小企业及企业客户。
AXSM vs FSUN — 直观对比
营收规模更大
AXSM
是对方的1.7倍
$110.0M
两年增速更快
AXSM
近两年复合增速
6.9%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $191.2M | $110.0M |
| 净利润 | — | $21.6M |
| 毛利率 | — | — |
| 营业利润率 | -33.1% | — |
| 净利率 | — | 19.6% |
| 营收同比 | 57.4% | — |
| 净利润同比 | — | -8.4% |
| 每股收益（稀释后） | — | $0.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMFSUN
| Q1 26 | $191.2M | $110.0M | ||
| Q4 25 | $196.0M | $110.2M | ||
| Q3 25 | $171.0M | $107.3M | ||
| Q2 25 | $150.0M | $105.6M | ||
| Q1 25 | $121.5M | $96.2M | ||
| Q4 24 | $118.8M | $98.7M | ||
| Q3 24 | $104.8M | $98.2M | ||
| Q2 24 | $87.2M | $96.2M |
净利润AXSMFSUN
| Q1 26 | — | $21.6M | ||
| Q4 25 | $-28.6M | $24.8M | ||
| Q3 25 | $-47.2M | $23.2M | ||
| Q2 25 | $-48.0M | $26.4M | ||
| Q1 25 | $-59.4M | $23.6M | ||
| Q4 24 | $-74.9M | $16.4M | ||
| Q3 24 | $-64.6M | $22.4M | ||
| Q2 24 | $-79.3M | $24.6M |
营业利润率AXSMFSUN
| Q1 26 | -33.1% | — | ||
| Q4 25 | -13.8% | 29.0% | ||
| Q3 25 | -27.0% | 26.4% | ||
| Q2 25 | -24.5% | 31.2% | ||
| Q1 25 | -46.9% | 30.9% | ||
| Q4 24 | -61.1% | 20.4% | ||
| Q3 24 | -59.8% | 29.1% | ||
| Q2 24 | -89.5% | 32.3% |
净利率AXSMFSUN
| Q1 26 | — | 19.6% | ||
| Q4 25 | -14.6% | 22.5% | ||
| Q3 25 | -27.6% | 21.6% | ||
| Q2 25 | -32.0% | 25.0% | ||
| Q1 25 | -48.9% | 24.5% | ||
| Q4 24 | -63.1% | 16.6% | ||
| Q3 24 | -61.7% | 22.8% | ||
| Q2 24 | -91.0% | 25.5% |
每股收益（稀释后）AXSMFSUN
| Q1 26 | — | $0.76 | ||
| Q4 25 | $-0.55 | $0.89 | ||
| Q3 25 | $-0.94 | $0.82 | ||
| Q2 25 | $-0.97 | $0.93 | ||
| Q1 25 | $-1.22 | $0.83 | ||
| Q4 24 | $-1.54 | $0.57 | ||
| Q3 24 | $-1.34 | $0.79 | ||
| Q2 24 | $-1.67 | $0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $305.1M | $413.7M |
| 总债务越低越好 | $70.0M | — |
| 股东权益账面价值 | — | $1.2B |
| 总资产 | $713.6M | $8.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AXSMFSUN
| Q1 26 | $305.1M | $413.7M | ||
| Q4 25 | $322.9M | $652.6M | ||
| Q3 25 | $325.3M | $659.9M | ||
| Q2 25 | $303.0M | $785.1M | ||
| Q1 25 | $300.9M | $621.4M | ||
| Q4 24 | $315.4M | $615.9M | ||
| Q3 24 | $327.3M | $573.7M | ||
| Q2 24 | $315.7M | $535.8M |
总债务AXSMFSUN
| Q1 26 | $70.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AXSMFSUN
| Q1 26 | — | $1.2B | ||
| Q4 25 | $88.3M | $1.2B | ||
| Q3 25 | $73.7M | $1.1B | ||
| Q2 25 | $73.1M | $1.1B | ||
| Q1 25 | $53.2M | $1.1B | ||
| Q4 24 | $57.0M | $1.0B | ||
| Q3 24 | $92.9M | $1.0B | ||
| Q2 24 | $102.9M | $996.6M |
总资产AXSMFSUN
| Q1 26 | $713.6M | $8.6B | ||
| Q4 25 | $689.8M | $8.5B | ||
| Q3 25 | $669.3M | $8.5B | ||
| Q2 25 | $639.8M | $8.4B | ||
| Q1 25 | $596.7M | $8.2B | ||
| Q4 24 | $568.5M | $8.1B | ||
| Q3 24 | $561.5M | $8.1B | ||
| Q2 24 | $548.2M | $8.0B |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXSM
| Product sales, net | $189.4M | 99% |
| Royalty revenue and milestone revenue | $1.8M | 1% |
FSUN
| Net Interest Income | $82.8M | 75% |
| Noninterest Income | $27.2M | 25% |
